Skip to main content
OpenTrials

Clinical trial condition

Myoclonic Epilepsies, Progressive

Explore clinical trials studying Myoclonic Epilepsies, Progressive. Study availability and eligibility vary by location and protocol.

7 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Myoclonic Epilepsies, Progressive trial results

Recruiting

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

NCT01694940

Conditions
Abnormalities, Multiple, Acid-Base Imbalance, Acidosis, +86 more
Locations
  • University of California San Diego San Diego, California, United States
  • Lucile Packard Children's Hospital Stanford, California, United States
  • Children's Hospital of Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 17 locations
View Trial Details
Completed

OMT-28 in Patients With Primary Mitochondrial Disease (PMD) (PMD-OPTION)

NCT05972954

Conditions
Acid-Base Imbalance, Acidosis, Acidosis, Lactic, +44 more
Locations
  • Universitätsklinikum Bonn, Sektion Neuromuskuläre Erkrankungen, Klinik und Poliklinik für Neurologie, Venusberg-Campus 1, Gebäude 80, NPP Bonn, Germany
  • Medizinisch Fakultät der Martin-Luther-Universität Halle-Wittenberg Universitätsklinik und Poliklinik für Neurologie Universitätsklinikum , Ernst-Grube-Str. 40 Halle, Germany
  • Friedrich-Baur-Institut an der Neurologischen Klinik und Poliklinik, Klinikum der Universität München, Ludwig-Maximilians-Universität (LMU Klinikum), Ziemssenstr. 1a Munich, Germany
  • IRCCS Institute of Neurological Science of Bologna, University of Bologna, Department of Biomedical and Neuromotor Science (DIBINEM), Ospedale Bellaria Via Altura, 3 Bologna, Italy
View Trial Details
Completed

A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease

NCT05218655

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +36 more
Locations
  • University of California, San Diego Altman Clinical and Translational Research Institute La Jolla, California, United States
  • Stanford University Stanford, California, United States
  • Yale Medicine New Haven, Connecticut, United States
  • Children's National Washington D.C., District of Columbia, United States
View all 26 locations
View Trial Details
Completed

Ketogenic Diet in Lafora Disease

NCT00007124

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +23 more
Locations
  • National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
View Trial Details

Related conditions